Neuland Laboratories Limited (BOM:524558)
12,960
-219 (-1.66%)
At close: Feb 12, 2026
Neuland Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 2,601 | 3,001 | 1,635 | 638.22 | 806.31 |
Depreciation & Amortization | 642.23 | 586.44 | 515.22 | 475.59 | 383.98 |
Other Amortization | 13.24 | 10.56 | 12.56 | 14.81 | 12.85 |
Loss (Gain) From Sale of Assets | 73.11 | 4.02 | 8.71 | 18.08 | -130.93 |
Loss (Gain) From Sale of Investments | -840.86 | - | - | - | - |
Provision & Write-off of Bad Debts | 17.01 | -2.5 | 46.7 | 5.68 | 38.53 |
Other Operating Activities | 90.18 | -80.22 | 282.11 | 127.36 | 290.71 |
Change in Accounts Receivable | 549.07 | -86.63 | -1,343 | -171 | -300.75 |
Change in Inventory | -353.35 | -711.89 | -140.23 | -176.02 | -280.6 |
Change in Accounts Payable | 587.57 | 203.28 | 543.6 | -397.17 | 366.46 |
Change in Other Net Operating Assets | -205.44 | -312.09 | 811.58 | 68.35 | 707.06 |
Operating Cash Flow | 3,174 | 2,612 | 2,372 | 603.89 | 1,894 |
Operating Cash Flow Growth | 21.52% | 10.10% | 292.81% | -68.11% | 230.24% |
Capital Expenditures | -2,065 | -1,437 | -661.29 | -976.86 | -1,054 |
Sale of Property, Plant & Equipment | 11.64 | 12.63 | 14.91 | 4.36 | 0.09 |
Sale (Purchase) of Real Estate | 954.31 | - | - | -10.15 | - |
Investment in Securities | -999.7 | 3.37 | - | - | 188.13 |
Other Investing Activities | -883.17 | -76.17 | 31.39 | 27.48 | 21.51 |
Investing Cash Flow | -2,982 | -1,497 | -614.99 | -955.16 | -844.24 |
Short-Term Debt Issued | - | - | - | 347.95 | - |
Long-Term Debt Issued | 947.78 | 88.22 | 30.99 | 451.27 | 363.65 |
Total Debt Issued | 947.78 | 88.22 | 30.99 | 799.22 | 363.65 |
Short-Term Debt Repaid | - | -111.58 | -810.57 | - | -1,114 |
Long-Term Debt Repaid | -434.76 | -400.61 | -382.7 | -247.93 | -171.27 |
Total Debt Repaid | -434.76 | -512.19 | -1,193 | -247.93 | -1,286 |
Net Debt Issued (Repaid) | 513.02 | -423.97 | -1,162 | 551.3 | -921.98 |
Common Dividends Paid | -179.62 | -128.3 | -64.15 | -38.49 | -25.66 |
Other Financing Activities | -83.8 | -140.55 | -131.53 | -135.59 | -188.96 |
Financing Cash Flow | 249.61 | -692.82 | -1,358 | 377.22 | -1,137 |
Foreign Exchange Rate Adjustments | 1.67 | -0.49 | 4.07 | 0.62 | -0.46 |
Net Cash Flow | 443.55 | 421.6 | 403.25 | 26.56 | -87.68 |
Free Cash Flow | 1,109 | 1,175 | 1,711 | -372.97 | 839.65 |
Free Cash Flow Growth | -5.61% | -31.32% | - | - | 882.69% |
Free Cash Flow Margin | 7.51% | 7.54% | 14.36% | -3.92% | 8.96% |
Free Cash Flow Per Share | 86.45 | 91.59 | 133.35 | -29.07 | 65.44 |
Cash Interest Paid | 83.8 | 140.55 | 131.53 | 135.59 | 188.96 |
Cash Income Tax Paid | 747.26 | 1,116 | 436.28 | 204.93 | 52.73 |
Levered Free Cash Flow | -137.99 | 409.9 | 1,359 | -763 | 606.8 |
Unlevered Free Cash Flow | -101.8 | 479.11 | 1,424 | -703.42 | 686.8 |
Change in Working Capital | 577.85 | -907.32 | -128.34 | -675.85 | 492.17 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.